-
RBC Capital Cuts PT on Concordia Int'l (CXRX) to $27 Following Q2 REsults
-
RBC Affirms Concordia (CXRX) at 'Outperform' as Q2 Profit Meets Lowered Expectations
-
Concordia Healthcare Announces Addition to Senior Executive Team, Presentation at RBC Investor Conference, and Release Date for Fourth Quarter and 2015 Results
-
Concordia Healthcare Completes AMCo Acquisition
-
Concordia Healthcare (CXRX) Completes 3M Common Stock Offering
-
Concordia Healthcare Completes US$520 Million Public Offering of Common Shares at US$65.00 per Common Share
-
Concordia Healthcare Announces Terms of US$520 Million Public Offering of Common Shares
-
Concordia Healthcare (CXRX) Files to Sell up to 8M Common Shares
-
Concordia Healthcare Announces Public Offering of Common Shares
-
Concordia Healthcare (CXRX) to Acquire Amdipharm Mercury in ~$3.5B Deal
-
Concordia Healthcare to Acquire Amdipharm Mercury Limited (AMCo) for US$3.5 Billion Creating a Global Platform to Facilitate Future Growth

